Anticancer effect and safety of doxorubicin and nutraceutical sulforaphane liposomal formulation in triple-negative breast cancer (TNBC) animal model

Anticancer effect and safety of doxorubicin and nutraceutical sulforaphane liposomal formulation in triple-negative breast cancer (TNBC) animal model

Female breast cancer is the most deadly cancer in women worldwide. The triple-negative breast cancer subtype therapies, due to the lack of specific drug targets, are still based on systemic chemotherapy with doxorubicin, which is burdened with severe adverse effects. To enhance therapeutic success a...

Full description

Bibliographic Details
Main Authors: Anna Pogorzelska, Maciej Mazur, Marta Świtalska, Joanna Wietrzyk, Dawid Sigorski, Krzysztof Fronczyk, Katarzyna Wiktorska
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Triple-negative breast cancer models
Sulforaphane
Doxorubicin adverse effects
Combination therapy
Drug carriers
Chemoprotection
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223002780

Internet

http://www.sciencedirect.com/science/article/pii/S0753332223002780

Similar Items